ALL
-
2017.09.27
Topics
Presentation at Cell and Gene Meeting on the Mesa
-
2017.06.05
Topics
Holding a Focus Session in ISSCR 2017 in Boston
-
2017.05.17
News
[Press Release] Universal Cells, Inc’s Gene Editing Strategy Published in Nature Biotechnology
-
2017.03.23
News
[Press Release] The Results from Athersys’ Phase 2 Trial of MultiStem Cell Therapy for Treating Ischemic Stroke Patients in the United States and Europe Published in Lancet Neurology
-
2017.01.31
News
[Press Release]Announcement on transfer of business relating to ophthalmic surgical adjuvant containing BBG250
-
2017.01.11
News
Presentation at 2017 JP Morgan Healthcare Conference on Wednesday January 11, 2017 at 4:00pm PT (Webcast available)
-
2017.09.27
News
Presentation at Cell and Gene Meeting on the Mesa
-
2017.06.05
News
Holding a Focus Session in ISSCR 2017 in Boston
-
2017.05.17
News
[Press Release] Universal Cells, Inc’s Gene Editing Strategy Published in Nature Biotechnology
-
2017.03.23
News
[Press Release] The Results from Athersys’ Phase 2 Trial of MultiStem Cell Therapy for Treating Ischemic Stroke Patients in the United States and Europe Published in Lancet Neurology
-
2017.01.31
News
[Press Release]Announcement on transfer of business relating to ophthalmic surgical adjuvant containing BBG250
-
2017.01.11
News
Presentation at 2017 JP Morgan Healthcare Conference on Wednesday January 11, 2017 at 4:00pm PT (Webcast available)